Invicta Diagnostic's IPO debuted strongly on December 8, listing at ₹100, a 17.65% premium over its issue price of ₹85. The ...

Shares of Invicta Diagnostic listed at Rs 100 per share on the Emerge platform of the National Stock Exchange (NSE). The Rs 28.12 crore issue had a price band of Rs 80-85 per share.

Invicta Diagnostic was trading at Rs 95 on the NSE, a 11.76% premium to the issue price of Rs 85. Invicta Diagnostic's IPO was subscribed 4.05 times. The issue opened for bidding on 1 December 2025 ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

Invicta Diagnostic is set to debut on the NSE SME platform on December 8, following a successful IPO that raised 28.12 crore.

A recently disclosed Tri-Century Eye Care data breach stemming from a ransomware attack affects roughly 200,000 individuals.

Discover 10 high-paying, hard-to-fill jobs offering $30+ an hour, what's driving the demand, and how these roles could boost ...

Aurangzeb also acknowledged a point raised earlier by Minister for National Food Security Rana Tanveer Hussain regarding ...

AI systems are racing through standardized tests, acing bar exams and coding challenges that once seemed safely human. Yet in daily life, the same tools still hallucinate facts, misread context and ...

Explore campus events in Tiruchi, highlighting art competitions, heritage expos, AI workshops, and educational initiatives ...

The Faculty of Medicine, Chulalongkorn University, in collaboration with the Faculty of Engineering, has developed “Deep GI,” ...

The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...